conducted target trial emulations comparing dual GLP-1/GIP agonists to GLP-1 monotherapy in patients with type 2 diabetes, finding that dual agonists were linked to numerically lower risks of MALOs, although confidence intervals overlapped, suggesting that extended observation period and larger patient cohorts may be needed to definitively establish comparative effectiveness [61]
You might also experience increased stomach pain, nausea, or signs of acid reflux due to both medications affecting the digestive system
10.1039/C8MT00142A 67 WangL.HarrisS
The impaired mitophagy due to failed autophagy induction contributes to synaptic dysfunction and cognitive deficits by triggering A and tau accumulation through increases in oxidative damage and cellular energy deficits, which in turn impaired mitophagy (Mary et al., 2022)
Youll still notice hunger just not as often or as strong
N.FaggiS.KofmanV.RothL.et al